RYTM FY2025 SEC EDGAR DEF 14A #93 of 168 in industry

Rhythm Pharmaceuticals, Inc. CEO pay ratio

The CEO earned $17.5M in FY2025 against median worker pay of $487,348 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
DE
Filing date
2026-04-29
Industry
Chemicals & Pharmaceuticals
Industry rank
#93/168

Data updated August 2026

Subscribe to Rhythm Pharmaceuticals, Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
36:1
Below Average (Scale: 0–1000:1)
CEO pay
$17.5M
Median worker
$487,348

Answer first

Rhythm Pharmaceuticals, Inc.'s FY2025 CEO total of $17.5M ranks #217 of 1,423 complete filings; its 36:1 pay ratio ranks #1091. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $487,348. Industry placement uses the FY2025 SIC-28 peer cohort (# 93 of 168, 45th percentile - below the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#217
$17.5M of 1,423 FY2025
Ratio rank
#1091
36:1 of 1,423
Industry pct
45th
below the industry median pay ratio

How Rhythm Pharmaceuticals, Inc. ranks nationally

Rhythm Pharmaceuticals, Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$17,544,525 Top 15% higher than 85% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). Below this entry. $10,000,000–$12,500,000: 139 companies (10%). Below this entry. $12,500,000–$15,000,000: 91 companies (6%). Below this entry. $15,000,000–$17,500,000: 88 companies (6%). Below this entry. $17,500,000–$20,000,000: 54 companies (4%). This entry sits in this band. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Rhythm Pharmaceuticals, Inc. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($17.5M) against pay ratio (36:1) for Rhythm Pharmaceuticals, Inc. (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both04601554.09203107.913804661.918406215.934.6:136.6:138.5:140.4:142.4:1CEO total payPay ratio (CEO : median worker)Rhythm Pharmaceuticals, Inc., CEO total pay: 17544525 · Pay ratio (CEO : median worker): 36:1Rhythm Pharmaceuticals, Inc.Cryoport, Inc., CEO total pay: 2392161 · Pay ratio (CEO : median worker): 37:1Cryoport, Inc.Evolus, Inc., CEO total pay: 6412214 · Pay ratio (CEO : median worker): 35:1Evolus, Inc.Xenon Pharmaceuticals Inc., CEO total pay: 9118206 · Pay ratio (CEO : median worker): 37:1Xenon Pharmaceuticals Inc.Kiniksa Pharmaceuticals International, plc, CEO total pay: 310707 · Pay ratio (CEO : median worker): 35:1Kiniksa Pharmaceuticals International, plcBridgeBio Pharma, Inc., CEO total pay: 14944585 · Pay ratio (CEO : median worker): 37:1BridgeBio Pharma, Inc.
Rhythm Pharmaceuticals, Inc. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Rhythm Pharmaceuticals, Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Rhythm Pharmaceuticals, Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
36:1
FY2025
vs prior FY
0:1
from FY2024 36:1
CEO $ YoY
+20%
$17.5M latest
Filings shown
5
FY2021–2025
Rhythm Pharmaceuticals, Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $6.5M - $358,798 18:1 -
2022 $3.3M -49% $277,147 12:1 -6:1
2023 $7.2M +117% $314,368 23:1 +11:1
2024 $14.7M +103% $407,326 36:1 +13:1
2025 $17.5M +20% $487,348 36:1 0:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1649904, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
36:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$17.5M
Companies in Industry
168
vs. Industry Median
Below
#93 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Rhythm Pharmaceuticals, Inc.: MODEST · PEAK pay ratio

Rhythm Pharmaceuticals, Inc.'s FY2025 CEO total $17.5M ranks #217 of 1,423 complete filings (higher third by dollars). the CEO earned 36× the median employee ($487,348) in FY2025.

Median employee $487,348 (ELITE-MED); MODEST · PEAK stamps put about 36 median-wage years per CEO year.

CEO Total Pay

$17.5M

FY2025 Summary Compensation, well above median

Pay Ratio

36:1

Below typical

Rhythm Pharmaceuticals, Inc. in the higher-dollar third

Rhythm Pharmaceuticals, Inc.'s FY2025 CEO total $17.5M ranks #217 of 1,423 complete filings (higher third by dollars). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Rhythm Pharmaceuticals, Inc.'s $17.5M CEO total is above the $7.9M industry median CEO pay.

Dollar rank #217 and ratio rank #1091 split - treat 36:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$17.5M
Median Employee Pay
$487,348
Pay Ratio
36:1
Filing Date
2026-04-29

Company Info

Ticker
RYTM
CIK
1649904
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 1649904, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Rhythm Pharmaceuticals, Inc.'s FY2025 CEO total $17.5M ranks #217 of 1,423 complete filings (higher third by dollars).

Read with Rhythm Pharmaceuticals, Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · PEAK · ELITE-MED.

Crown Holdings, Inc. · PEAK

ABS(ceo_total_comp) peer at $17.5M (Δ $20K lighter vs Rhythm Pharmaceuticals, Inc.); HIGH · PAR-MED vs this page's MODEST · PEAK · ELITE-MED.
Corteva, Inc. · PEAK

ABS(ceo_total_comp) peer at $17.5M (Δ $32K lighter vs Rhythm Pharmaceuticals, Inc.); STEEP · HIGH-MED vs this page's MODEST · PEAK · ELITE-MED.
Eog Resources Inc · PEAK

ABS(ceo_total_comp) peer at $17.6M (Δ $32K heavier vs Rhythm Pharmaceuticals, Inc.); MID · ELITE-MED vs this page's MODEST · PEAK · ELITE-MED.
Caterpillar Inc · PEAK

ABS(ceo_total_comp) peer at $17.5M (Δ $51K lighter vs Rhythm Pharmaceuticals, Inc.); STEEP · HIGH-MED vs this page's MODEST · PEAK · ELITE-MED.
Cryoport, Inc. (SIC 28 pole)

Cryoport, Inc. stamps MODEST · MID$ nearest in-SIC by ABS(pay_ratio) to Rhythm Pharmaceuticals, Inc.'s MODEST filing.
National dual ranks · #217/#1091

Rhythm Pharmaceuticals, Inc.'s FY2025 package sits #217 by CEO dollars and #1091 by ratio under PEAK · MODEST.
Ratio primer · MODEST

Rhythm Pharmaceuticals, Inc.'s MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Rhythm Pharmaceuticals, Inc. (CIK 1649904), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.